Inventor
DORICH STÉPHANE
CA13 patents
⚠️ This page may combine multiple inventors who share the name “DORICH STÉPHANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VENTUS THERAPEUTICS U S INC
12 patentsUS11618751B1Apr 4, 2023
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
VENTUS THERAPEUTICS U S INC17 citations92
US11319319B1May 3, 2022
Compounds for inhibiting NLRP3 and uses thereof
VENTUS THERAPEUTICS U S INC45 citations91
US12281112B2Apr 22, 2025
Compounds for inhibiting NLRP3 and uses thereof
VENTUS THERAPEUTICS U S INC1 citations72
US12195460B2Jan 14, 2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
VENTUS THERAPEUTICS U S INC3 citations72
US12168657B2Dec 17, 2024
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
VENTUS THERAPEUTICS U S INC3 citations70
US12441728B2Oct 14, 2025
Pyridazine compounds for inhibiting NLRP3
VENTUS THERAPEUTICS U S INC0 citations60
US12312350B2May 27, 2025
Compounds for inhibiting NLRP3 and uses thereof
VENTUS THERAPEUTICS U S INC0 citations60
US12398136B2Aug 26, 2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
VENTUS THERAPEUTICS U S INC0 citations59
US12331048B2Jun 17, 2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
VENTUS THERAPEUTICS U S INC0 citations59
US12312351B2May 27, 2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
VENTUS THERAPEUTICS U S INC0 citations59
US12410167B2Sep 9, 2025
Pyridazine compounds for inhibiting NLRP3
VENTUS THERAPEUTICS U S INC0 citations58
US12351578B2Jul 8, 2025
Compounds for inhibiting NLRP3 and uses thereof
VENTUS THERAPEUTICS U S INC0 citations57